National Research Corporation (NRC)
NASDAQ: NRC · Real-Time Price · USD
18.70
-0.60 (-3.11%)
At close: Dec 19, 2025, 4:00 PM EST
18.70
0.00 (0.00%)
After-hours: Dec 19, 2025, 4:29 PM EST
National Research Revenue
National Research had revenue of $34.61M in the quarter ending September 30, 2025, a decrease of -3.38%. This brings the company's revenue in the last twelve months to $139.10M, down -3.50% year-over-year. In the year 2024, National Research had annual revenue of $143.06M, down -3.72%.
Revenue (ttm)
$139.10M
Revenue Growth
-3.50%
P/S Ratio
3.16
Revenue / Employee
$377,995
Employees
368
Market Cap
423.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 143.06M | -5.52M | -3.72% |
| Dec 31, 2023 | 148.58M | -2.99M | -1.97% |
| Dec 31, 2022 | 151.57M | 3.61M | 2.44% |
| Dec 31, 2021 | 147.95M | 14.68M | 11.01% |
| Dec 31, 2020 | 133.28M | 5.30M | 4.14% |
| Dec 31, 2019 | 127.98M | 8.30M | 6.93% |
| Dec 31, 2018 | 119.69M | 2.13M | 1.81% |
| Dec 31, 2017 | 117.56M | 8.18M | 7.47% |
| Dec 31, 2016 | 109.38M | 7.04M | 6.88% |
| Dec 31, 2015 | 102.34M | 3.51M | 3.55% |
| Dec 31, 2014 | 98.84M | 6.25M | 6.75% |
| Dec 31, 2013 | 92.59M | 6.17M | 7.14% |
| Dec 31, 2012 | 86.42M | 10.65M | 14.06% |
| Dec 31, 2011 | 75.77M | 12.37M | 19.51% |
| Dec 31, 2010 | 63.40M | 5.71M | 9.89% |
| Dec 31, 2009 | 57.69M | 6.68M | 13.09% |
| Dec 31, 2008 | 51.01M | 2.09M | 4.27% |
| Dec 31, 2007 | 48.92M | 5.15M | 11.77% |
| Dec 31, 2006 | 43.77M | 11.33M | 34.95% |
| Dec 31, 2005 | 32.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NRC News
- 17 days ago - NRC Health Partners with Mosaic Life Care to Advance Patient Experience Across the Midwest - Business Wire
- 4 weeks ago - NRC Health Appoints David Burik as Executive Vice President, Strategic Insights - Business Wire
- 5 weeks ago - NRC Health Partners with BJC HealthCare to Advance Experience Excellence Across a Unified Network - Business Wire
- 6 weeks ago - North Mississippi Health Services Chooses NRC Health to Elevate Care Experiences and Community Engagement - Business Wire
- 7 weeks ago - National Research Corporation (NRC) Q3 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 7 weeks ago - NRC Health Announces Third Quarter 2025 Results - Business Wire
- 2 months ago - Mercy Earns National Honor for Excellence in Patient Experience - PRNewsWire
- 2 months ago - NRC Health Honors 2025 Leaders in Patient Experience and Loyalty - Business Wire